Cargando…
Tumor expression of CXCL12 and survival of patients with colorectal cancer: A meta-analysis
C-X-C motif chemokine ligand 12 (CXCL12) has been suggested as a possible biomarker of poor prognosis in patients with various malignancies. However, the association between tumor expression of CXCL12 and survival of patients with colorectal cancer (CRC) remains to be comprehensively analyzed. A met...
Autores principales: | Zhang, Shuqi, Li, Guoxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641825/ https://www.ncbi.nlm.nih.gov/pubmed/36420080 http://dx.doi.org/10.3892/ol.2022.13556 |
Ejemplares similares
-
A meta-analysis of CXCL12 expression for cancer prognosis
por: Samarendra, Harsh, et al.
Publicado: (2017) -
The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis
por: Xu, Ke, et al.
Publicado: (2018) -
Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis’
por: Mei, Zu-Bing, et al.
Publicado: (2018) -
Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
por: Yoshuantari, Naomi, et al.
Publicado: (2018) -
Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis”
por: Gordon-Weeks, Alex
Publicado: (2018)